10th Annual Dr. Richard L. Kempson Diagnostic Pathology Course Updates in Breast, Gastrointestinal, Genitourinary and Gynecologic Pathology 2025

+ Target Audience: practicing surgical pathologists, subspecialty fellows

+ Information:

An advanced, case-based surgical pathology update across breast, GI, GU, and gynecologic subspecialties. Faculty emphasize pattern recognition, differential diagnosis, ancillary testing, and clinically impactful reporting that aligns with current classifications and guidelines.

What You Will Learn

• High-yield morphologic patterns and differential traps in breast, GI, GU, and GYN pathology

• How to apply contemporary classification systems and grading/staging criteria

• Smart use of immunohistochemistry and molecular assays: when they change management—and when they don’t

• Margin assessment, biomarker reporting, and synoptic elements that drive therapy

• Diagnostic pitfalls, artifacts, and look-alikes illustrated with whole-slide images

• Practical sign-out strategies: triage, checklists, and wording that improves clarity and reduces addenda

Event Details

• Format: Didactic lectures with unknowns, interactive case discussions, and take-home slide sets/WSIs

• Structure: Disease-site blocks with pearls, pitfall galleries, and algorithmic flowcharts

• Access: Built for next-day implementation at the microscope and in tumor boards

Who Should Attend
Practicing surgical pathologists, subspecialty fellows, senior residents, pathology assistants, and laboratorians who want a concentrated, practice-ready update in breast, GI, GU, and GYN pathology.

Why Attend

• Refresh diagnostic accuracy on difficult and common entities that dominate daily sign-out

• Standardize ancillary testing and reporting to support precise, timely therapy decisions

• Bring back practical checklists, synoptic prompts, and phrasing that reduce ambiguity

+ Topics:

1.   Esophagitis: Beyond Reflux (Teri Longacre M.D.)
2.   Lynch, BRCA and Beyond: Gynecologic Malignancies in Familial Cancer Syndromes (Anne Mills M.D.)
3.   Mergng Molecular and Morphology in Endometrial Cancer: Building on Dr. Kempson’s Diagnostic Legacy (Anne Mills M.D.)
4.   Mimics Of Urothelial Neoplasia
5.   Biomarker Driven Breast Cancer Decisions: What A Pathologist Needs To Know (Kimberly Allison M.D.)
6.   From p16 to PDL1 Biomarkers in Cervical Squamous Neoplasia (Anne Mills M.D.)
7.   Adrenal Gland Pathology in Routine Clinical Practice
8.   CAP Breast Cancer Reporting Protocols: Answers to Common Questions (Kimberly Allison M.D.)
9.   Gastritis: When It Isn’t Helicobacter…Or Is It? (Teri Longacre M.D.)
10.   Gastric Polyps (Teri Longacre M.D.)
11.   Intraductal Proliferations Of The Prostate: A Deep Dive
12.   Current Grading Of Prostate Cancer: What Really Matters?
13.   IBD: Imitations, Complications and Recommendations (Teri Longacre M.D.)
14.   HER2 Testing In Breast Cancer: Best Practices And Remaining Challenges (Kimberly Allison M.D.)
15.   Ovarian Oddities: Adnexal Diagnoses Not To Miss (Anne Mills M.D.)
16.   Roadmap for Navigating Breast in situ Proliferations (Kimberly Allison M.D.)
17.   Challenging Cases Illustrating Major Breast Pathology Pitfalls (Kimberly Allison M.D.)
18.   Don’t Stop At Smooth Muscle: Uterine Mesenchymal Tumors to Know (Anne Mills M.D.)
19.   When Is A GIST Not Just Another GIST? Differential Diagnosis and New Developments (Teri Longacre M.D.)
20.   Renal Tumors With Clear Cytoplasm: A Common Problem